Global Oncology Companion Diagnostic Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Oncology Companion Diagnostic market size was valued at US$ million in 2023. With growing demand in downstream market, the Oncology Companion Diagnostic is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Oncology Companion Diagnostic market. Oncology Companion Diagnostic are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Oncology Companion Diagnostic. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Oncology Companion Diagnostic market.
A companion diagnostic is a diagnostic test used as a companion to a therapeutic drug to determine its applicability to a specific person.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Oncology Companion Diagnostic market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Oncology Companion Diagnostic market. It may include historical data, market segmentation by Type (e.g., Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS)), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Oncology Companion Diagnostic market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Oncology Companion Diagnostic market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Oncology Companion Diagnostic industry. This include advancements in Oncology Companion Diagnostic technology, Oncology Companion Diagnostic new entrants, Oncology Companion Diagnostic new investment, and other innovations that are shaping the future of Oncology Companion Diagnostic.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Oncology Companion Diagnostic market. It includes factors influencing customer ' purchasing decisions, preferences for Oncology Companion Diagnostic product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Oncology Companion Diagnostic market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Oncology Companion Diagnostic market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Oncology Companion Diagnostic market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Oncology Companion Diagnostic industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Oncology Companion Diagnostic market.
Market Segmentation:
Oncology Companion Diagnostic market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
According to our LPI (LP Information) latest study, the global Oncology Companion Diagnostic market size was valued at US$ million in 2023. With growing demand in downstream market, the Oncology Companion Diagnostic is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Oncology Companion Diagnostic market. Oncology Companion Diagnostic are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Oncology Companion Diagnostic. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Oncology Companion Diagnostic market.
A companion diagnostic is a diagnostic test used as a companion to a therapeutic drug to determine its applicability to a specific person.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Oncology Companion Diagnostic market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Oncology Companion Diagnostic market. It may include historical data, market segmentation by Type (e.g., Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS)), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Oncology Companion Diagnostic market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Oncology Companion Diagnostic market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Oncology Companion Diagnostic industry. This include advancements in Oncology Companion Diagnostic technology, Oncology Companion Diagnostic new entrants, Oncology Companion Diagnostic new investment, and other innovations that are shaping the future of Oncology Companion Diagnostic.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Oncology Companion Diagnostic market. It includes factors influencing customer ' purchasing decisions, preferences for Oncology Companion Diagnostic product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Oncology Companion Diagnostic market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Oncology Companion Diagnostic market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Oncology Companion Diagnostic market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Oncology Companion Diagnostic industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Oncology Companion Diagnostic market.
Market Segmentation:
Oncology Companion Diagnostic market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
- Polymerase Chain Reaction (PCR)
- Next-Generation Sequencing (NGS)
- Immunohistochemistry (IHC)
- In situ hybridization (ISH)/Fluorescence in situ hybridization (FISH)
- Others
- Hospital
- Pathology/Diagnostic Laboratory
- Academic Medical Center
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Agilent Technologies, Inc.
- Illumina, Inc.
- Qiagen N.V.
- Thermo Fisher Scientific Inc.
- F. Hoffmann-La Roche Ltd.
- ARUP Laboratories
- Abbott
- Myriad Genetics, Inc.
- bioMйrieux SA
- Invivoscribe, Inc.
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Oncology Companion Diagnostic Market Size 2019-2030
2.1.2 Oncology Companion Diagnostic Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Oncology Companion Diagnostic Segment by Type
2.2.1 Polymerase Chain Reaction (PCR)
2.2.2 Next-Generation Sequencing (NGS)
2.2.3 Immunohistochemistry (IHC)
2.2.4 In situ hybridization (ISH)/Fluorescence in situ hybridization (FISH)
2.2.5 Others
2.3 Oncology Companion Diagnostic Market Size by Type
2.3.1 Oncology Companion Diagnostic Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Oncology Companion Diagnostic Market Size Market Share by Type (2019-2024)
2.4 Oncology Companion Diagnostic Segment by Application
2.4.1 Hospital
2.4.2 Pathology/Diagnostic Laboratory
2.4.3 Academic Medical Center
2.5 Oncology Companion Diagnostic Market Size by Application
2.5.1 Oncology Companion Diagnostic Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Oncology Companion Diagnostic Market Size Market Share by Application (2019-2024)
3 ONCOLOGY COMPANION DIAGNOSTIC MARKET SIZE BY PLAYER
3.1 Oncology Companion Diagnostic Market Size Market Share by Players
3.1.1 Global Oncology Companion Diagnostic Revenue by Players (2019-2024)
3.1.2 Global Oncology Companion Diagnostic Revenue Market Share by Players (2019-2024)
3.2 Global Oncology Companion Diagnostic Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 ONCOLOGY COMPANION DIAGNOSTIC BY REGIONS
4.1 Oncology Companion Diagnostic Market Size by Regions (2019-2024)
4.2 Americas Oncology Companion Diagnostic Market Size Growth (2019-2024)
4.3 APAC Oncology Companion Diagnostic Market Size Growth (2019-2024)
4.4 Europe Oncology Companion Diagnostic Market Size Growth (2019-2024)
4.5 Middle East & Africa Oncology Companion Diagnostic Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Oncology Companion Diagnostic Market Size by Country (2019-2024)
5.2 Americas Oncology Companion Diagnostic Market Size by Type (2019-2024)
5.3 Americas Oncology Companion Diagnostic Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Oncology Companion Diagnostic Market Size by Region (2019-2024)
6.2 APAC Oncology Companion Diagnostic Market Size by Type (2019-2024)
6.3 APAC Oncology Companion Diagnostic Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Oncology Companion Diagnostic by Country (2019-2024)
7.2 Europe Oncology Companion Diagnostic Market Size by Type (2019-2024)
7.3 Europe Oncology Companion Diagnostic Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Oncology Companion Diagnostic by Region (2019-2024)
8.2 Middle East & Africa Oncology Companion Diagnostic Market Size by Type (2019-2024)
8.3 Middle East & Africa Oncology Companion Diagnostic Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL ONCOLOGY COMPANION DIAGNOSTIC MARKET FORECAST
10.1 Global Oncology Companion Diagnostic Forecast by Regions (2025-2030)
10.1.1 Global Oncology Companion Diagnostic Forecast by Regions (2025-2030)
10.1.2 Americas Oncology Companion Diagnostic Forecast
10.1.3 APAC Oncology Companion Diagnostic Forecast
10.1.4 Europe Oncology Companion Diagnostic Forecast
10.1.5 Middle East & Africa Oncology Companion Diagnostic Forecast
10.2 Americas Oncology Companion Diagnostic Forecast by Country (2025-2030)
10.2.1 United States Oncology Companion Diagnostic Market Forecast
10.2.2 Canada Oncology Companion Diagnostic Market Forecast
10.2.3 Mexico Oncology Companion Diagnostic Market Forecast
10.2.4 Brazil Oncology Companion Diagnostic Market Forecast
10.3 APAC Oncology Companion Diagnostic Forecast by Region (2025-2030)
10.3.1 China Oncology Companion Diagnostic Market Forecast
10.3.2 Japan Oncology Companion Diagnostic Market Forecast
10.3.3 Korea Oncology Companion Diagnostic Market Forecast
10.3.4 Southeast Asia Oncology Companion Diagnostic Market Forecast
10.3.5 India Oncology Companion Diagnostic Market Forecast
10.3.6 Australia Oncology Companion Diagnostic Market Forecast
10.4 Europe Oncology Companion Diagnostic Forecast by Country (2025-2030)
10.4.1 Germany Oncology Companion Diagnostic Market Forecast
10.4.2 France Oncology Companion Diagnostic Market Forecast
10.4.3 UK Oncology Companion Diagnostic Market Forecast
10.4.4 Italy Oncology Companion Diagnostic Market Forecast
10.4.5 Russia Oncology Companion Diagnostic Market Forecast
10.5 Middle East & Africa Oncology Companion Diagnostic Forecast by Region (2025-2030)
10.5.1 Egypt Oncology Companion Diagnostic Market Forecast
10.5.2 South Africa Oncology Companion Diagnostic Market Forecast
10.5.3 Israel Oncology Companion Diagnostic Market Forecast
10.5.4 Turkey Oncology Companion Diagnostic Market Forecast
10.5.5 GCC Countries Oncology Companion Diagnostic Market Forecast
10.6 Global Oncology Companion Diagnostic Forecast by Type (2025-2030)
10.7 Global Oncology Companion Diagnostic Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Agilent Technologies, Inc.
11.1.1 Agilent Technologies, Inc. Company Information
11.1.2 Agilent Technologies, Inc. Oncology Companion Diagnostic Product Offered
11.1.3 Agilent Technologies, Inc. Oncology Companion Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Agilent Technologies, Inc. Main Business Overview
11.1.5 Agilent Technologies, Inc. Latest Developments
11.2 Illumina, Inc.
11.2.1 Illumina, Inc. Company Information
11.2.2 Illumina, Inc. Oncology Companion Diagnostic Product Offered
11.2.3 Illumina, Inc. Oncology Companion Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Illumina, Inc. Main Business Overview
11.2.5 Illumina, Inc. Latest Developments
11.3 Qiagen N.V.
11.3.1 Qiagen N.V. Company Information
11.3.2 Qiagen N.V. Oncology Companion Diagnostic Product Offered
11.3.3 Qiagen N.V. Oncology Companion Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Qiagen N.V. Main Business Overview
11.3.5 Qiagen N.V. Latest Developments
11.4 Thermo Fisher Scientific Inc.
11.4.1 Thermo Fisher Scientific Inc. Company Information
11.4.2 Thermo Fisher Scientific Inc. Oncology Companion Diagnostic Product Offered
11.4.3 Thermo Fisher Scientific Inc. Oncology Companion Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Thermo Fisher Scientific Inc. Main Business Overview
11.4.5 Thermo Fisher Scientific Inc. Latest Developments
11.5 F. Hoffmann-La Roche Ltd.
11.5.1 F. Hoffmann-La Roche Ltd. Company Information
11.5.2 F. Hoffmann-La Roche Ltd. Oncology Companion Diagnostic Product Offered
11.5.3 F. Hoffmann-La Roche Ltd. Oncology Companion Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 F. Hoffmann-La Roche Ltd. Main Business Overview
11.5.5 F. Hoffmann-La Roche Ltd. Latest Developments
11.6 ARUP Laboratories
11.6.1 ARUP Laboratories Company Information
11.6.2 ARUP Laboratories Oncology Companion Diagnostic Product Offered
11.6.3 ARUP Laboratories Oncology Companion Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 ARUP Laboratories Main Business Overview
11.6.5 ARUP Laboratories Latest Developments
11.7 Abbott
11.7.1 Abbott Company Information
11.7.2 Abbott Oncology Companion Diagnostic Product Offered
11.7.3 Abbott Oncology Companion Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Abbott Main Business Overview
11.7.5 Abbott Latest Developments
11.8 Myriad Genetics, Inc.
11.8.1 Myriad Genetics, Inc. Company Information
11.8.2 Myriad Genetics, Inc. Oncology Companion Diagnostic Product Offered
11.8.3 Myriad Genetics, Inc. Oncology Companion Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Myriad Genetics, Inc. Main Business Overview
11.8.5 Myriad Genetics, Inc. Latest Developments
11.9 bioMйrieux SA
11.9.1 bioMйrieux SA Company Information
11.9.2 bioMйrieux SA Oncology Companion Diagnostic Product Offered
11.9.3 bioMйrieux SA Oncology Companion Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 bioMйrieux SA Main Business Overview
11.9.5 bioMйrieux SA Latest Developments
11.10 Invivoscribe, Inc.
11.10.1 Invivoscribe, Inc. Company Information
11.10.2 Invivoscribe, Inc. Oncology Companion Diagnostic Product Offered
11.10.3 Invivoscribe, Inc. Oncology Companion Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Invivoscribe, Inc. Main Business Overview
11.10.5 Invivoscribe, Inc. Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Oncology Companion Diagnostic Market Size 2019-2030
2.1.2 Oncology Companion Diagnostic Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Oncology Companion Diagnostic Segment by Type
2.2.1 Polymerase Chain Reaction (PCR)
2.2.2 Next-Generation Sequencing (NGS)
2.2.3 Immunohistochemistry (IHC)
2.2.4 In situ hybridization (ISH)/Fluorescence in situ hybridization (FISH)
2.2.5 Others
2.3 Oncology Companion Diagnostic Market Size by Type
2.3.1 Oncology Companion Diagnostic Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Oncology Companion Diagnostic Market Size Market Share by Type (2019-2024)
2.4 Oncology Companion Diagnostic Segment by Application
2.4.1 Hospital
2.4.2 Pathology/Diagnostic Laboratory
2.4.3 Academic Medical Center
2.5 Oncology Companion Diagnostic Market Size by Application
2.5.1 Oncology Companion Diagnostic Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Oncology Companion Diagnostic Market Size Market Share by Application (2019-2024)
3 ONCOLOGY COMPANION DIAGNOSTIC MARKET SIZE BY PLAYER
3.1 Oncology Companion Diagnostic Market Size Market Share by Players
3.1.1 Global Oncology Companion Diagnostic Revenue by Players (2019-2024)
3.1.2 Global Oncology Companion Diagnostic Revenue Market Share by Players (2019-2024)
3.2 Global Oncology Companion Diagnostic Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 ONCOLOGY COMPANION DIAGNOSTIC BY REGIONS
4.1 Oncology Companion Diagnostic Market Size by Regions (2019-2024)
4.2 Americas Oncology Companion Diagnostic Market Size Growth (2019-2024)
4.3 APAC Oncology Companion Diagnostic Market Size Growth (2019-2024)
4.4 Europe Oncology Companion Diagnostic Market Size Growth (2019-2024)
4.5 Middle East & Africa Oncology Companion Diagnostic Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Oncology Companion Diagnostic Market Size by Country (2019-2024)
5.2 Americas Oncology Companion Diagnostic Market Size by Type (2019-2024)
5.3 Americas Oncology Companion Diagnostic Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Oncology Companion Diagnostic Market Size by Region (2019-2024)
6.2 APAC Oncology Companion Diagnostic Market Size by Type (2019-2024)
6.3 APAC Oncology Companion Diagnostic Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Oncology Companion Diagnostic by Country (2019-2024)
7.2 Europe Oncology Companion Diagnostic Market Size by Type (2019-2024)
7.3 Europe Oncology Companion Diagnostic Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Oncology Companion Diagnostic by Region (2019-2024)
8.2 Middle East & Africa Oncology Companion Diagnostic Market Size by Type (2019-2024)
8.3 Middle East & Africa Oncology Companion Diagnostic Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL ONCOLOGY COMPANION DIAGNOSTIC MARKET FORECAST
10.1 Global Oncology Companion Diagnostic Forecast by Regions (2025-2030)
10.1.1 Global Oncology Companion Diagnostic Forecast by Regions (2025-2030)
10.1.2 Americas Oncology Companion Diagnostic Forecast
10.1.3 APAC Oncology Companion Diagnostic Forecast
10.1.4 Europe Oncology Companion Diagnostic Forecast
10.1.5 Middle East & Africa Oncology Companion Diagnostic Forecast
10.2 Americas Oncology Companion Diagnostic Forecast by Country (2025-2030)
10.2.1 United States Oncology Companion Diagnostic Market Forecast
10.2.2 Canada Oncology Companion Diagnostic Market Forecast
10.2.3 Mexico Oncology Companion Diagnostic Market Forecast
10.2.4 Brazil Oncology Companion Diagnostic Market Forecast
10.3 APAC Oncology Companion Diagnostic Forecast by Region (2025-2030)
10.3.1 China Oncology Companion Diagnostic Market Forecast
10.3.2 Japan Oncology Companion Diagnostic Market Forecast
10.3.3 Korea Oncology Companion Diagnostic Market Forecast
10.3.4 Southeast Asia Oncology Companion Diagnostic Market Forecast
10.3.5 India Oncology Companion Diagnostic Market Forecast
10.3.6 Australia Oncology Companion Diagnostic Market Forecast
10.4 Europe Oncology Companion Diagnostic Forecast by Country (2025-2030)
10.4.1 Germany Oncology Companion Diagnostic Market Forecast
10.4.2 France Oncology Companion Diagnostic Market Forecast
10.4.3 UK Oncology Companion Diagnostic Market Forecast
10.4.4 Italy Oncology Companion Diagnostic Market Forecast
10.4.5 Russia Oncology Companion Diagnostic Market Forecast
10.5 Middle East & Africa Oncology Companion Diagnostic Forecast by Region (2025-2030)
10.5.1 Egypt Oncology Companion Diagnostic Market Forecast
10.5.2 South Africa Oncology Companion Diagnostic Market Forecast
10.5.3 Israel Oncology Companion Diagnostic Market Forecast
10.5.4 Turkey Oncology Companion Diagnostic Market Forecast
10.5.5 GCC Countries Oncology Companion Diagnostic Market Forecast
10.6 Global Oncology Companion Diagnostic Forecast by Type (2025-2030)
10.7 Global Oncology Companion Diagnostic Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Agilent Technologies, Inc.
11.1.1 Agilent Technologies, Inc. Company Information
11.1.2 Agilent Technologies, Inc. Oncology Companion Diagnostic Product Offered
11.1.3 Agilent Technologies, Inc. Oncology Companion Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Agilent Technologies, Inc. Main Business Overview
11.1.5 Agilent Technologies, Inc. Latest Developments
11.2 Illumina, Inc.
11.2.1 Illumina, Inc. Company Information
11.2.2 Illumina, Inc. Oncology Companion Diagnostic Product Offered
11.2.3 Illumina, Inc. Oncology Companion Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Illumina, Inc. Main Business Overview
11.2.5 Illumina, Inc. Latest Developments
11.3 Qiagen N.V.
11.3.1 Qiagen N.V. Company Information
11.3.2 Qiagen N.V. Oncology Companion Diagnostic Product Offered
11.3.3 Qiagen N.V. Oncology Companion Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Qiagen N.V. Main Business Overview
11.3.5 Qiagen N.V. Latest Developments
11.4 Thermo Fisher Scientific Inc.
11.4.1 Thermo Fisher Scientific Inc. Company Information
11.4.2 Thermo Fisher Scientific Inc. Oncology Companion Diagnostic Product Offered
11.4.3 Thermo Fisher Scientific Inc. Oncology Companion Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Thermo Fisher Scientific Inc. Main Business Overview
11.4.5 Thermo Fisher Scientific Inc. Latest Developments
11.5 F. Hoffmann-La Roche Ltd.
11.5.1 F. Hoffmann-La Roche Ltd. Company Information
11.5.2 F. Hoffmann-La Roche Ltd. Oncology Companion Diagnostic Product Offered
11.5.3 F. Hoffmann-La Roche Ltd. Oncology Companion Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 F. Hoffmann-La Roche Ltd. Main Business Overview
11.5.5 F. Hoffmann-La Roche Ltd. Latest Developments
11.6 ARUP Laboratories
11.6.1 ARUP Laboratories Company Information
11.6.2 ARUP Laboratories Oncology Companion Diagnostic Product Offered
11.6.3 ARUP Laboratories Oncology Companion Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 ARUP Laboratories Main Business Overview
11.6.5 ARUP Laboratories Latest Developments
11.7 Abbott
11.7.1 Abbott Company Information
11.7.2 Abbott Oncology Companion Diagnostic Product Offered
11.7.3 Abbott Oncology Companion Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Abbott Main Business Overview
11.7.5 Abbott Latest Developments
11.8 Myriad Genetics, Inc.
11.8.1 Myriad Genetics, Inc. Company Information
11.8.2 Myriad Genetics, Inc. Oncology Companion Diagnostic Product Offered
11.8.3 Myriad Genetics, Inc. Oncology Companion Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Myriad Genetics, Inc. Main Business Overview
11.8.5 Myriad Genetics, Inc. Latest Developments
11.9 bioMйrieux SA
11.9.1 bioMйrieux SA Company Information
11.9.2 bioMйrieux SA Oncology Companion Diagnostic Product Offered
11.9.3 bioMйrieux SA Oncology Companion Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 bioMйrieux SA Main Business Overview
11.9.5 bioMйrieux SA Latest Developments
11.10 Invivoscribe, Inc.
11.10.1 Invivoscribe, Inc. Company Information
11.10.2 Invivoscribe, Inc. Oncology Companion Diagnostic Product Offered
11.10.3 Invivoscribe, Inc. Oncology Companion Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Invivoscribe, Inc. Main Business Overview
11.10.5 Invivoscribe, Inc. Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Oncology Companion Diagnostic Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Polymerase Chain Reaction (PCR)
Table 3. Major Players of Next-Generation Sequencing (NGS)
Table 4. Major Players of Immunohistochemistry (IHC)
Table 5. Major Players of In situ hybridization (ISH)/Fluorescence in situ hybridization (FISH)
Table 6. Major Players of Others
Table 7. Oncology Companion Diagnostic Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 8. Global Oncology Companion Diagnostic Market Size by Type (2019-2024) & ($ Millions)
Table 9. Global Oncology Companion Diagnostic Market Size Market Share by Type (2019-2024)
Table 10. Oncology Companion Diagnostic Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 11. Global Oncology Companion Diagnostic Market Size by Application (2019-2024) & ($ Millions)
Table 12. Global Oncology Companion Diagnostic Market Size Market Share by Application (2019-2024)
Table 13. Global Oncology Companion Diagnostic Revenue by Players (2019-2024) & ($ Millions)
Table 14. Global Oncology Companion Diagnostic Revenue Market Share by Player (2019-2024)
Table 15. Oncology Companion Diagnostic Key Players Head office and Products Offered
Table 16. Oncology Companion Diagnostic Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Oncology Companion Diagnostic Market Size by Regions 2019-2024 & ($ Millions)
Table 20. Global Oncology Companion Diagnostic Market Size Market Share by Regions (2019-2024)
Table 21. Global Oncology Companion Diagnostic Revenue by Country/Region (2019-2024) & ($ millions)
Table 22. Global Oncology Companion Diagnostic Revenue Market Share by Country/Region (2019-2024)
Table 23. Americas Oncology Companion Diagnostic Market Size by Country (2019-2024) & ($ Millions)
Table 24. Americas Oncology Companion Diagnostic Market Size Market Share by Country (2019-2024)
Table 25. Americas Oncology Companion Diagnostic Market Size by Type (2019-2024) & ($ Millions)
Table 26. Americas Oncology Companion Diagnostic Market Size Market Share by Type (2019-2024)
Table 27. Americas Oncology Companion Diagnostic Market Size by Application (2019-2024) & ($ Millions)
Table 28. Americas Oncology Companion Diagnostic Market Size Market Share by Application (2019-2024)
Table 29. APAC Oncology Companion Diagnostic Market Size by Region (2019-2024) & ($ Millions)
Table 30. APAC Oncology Companion Diagnostic Market Size Market Share by Region (2019-2024)
Table 31. APAC Oncology Companion Diagnostic Market Size by Type (2019-2024) & ($ Millions)
Table 32. APAC Oncology Companion Diagnostic Market Size Market Share by Type (2019-2024)
Table 33. APAC Oncology Companion Diagnostic Market Size by Application (2019-2024) & ($ Millions)
Table 34. APAC Oncology Companion Diagnostic Market Size Market Share by Application (2019-2024)
Table 35. Europe Oncology Companion Diagnostic Market Size by Country (2019-2024) & ($ Millions)
Table 36. Europe Oncology Companion Diagnostic Market Size Market Share by Country (2019-2024)
Table 37. Europe Oncology Companion Diagnostic Market Size by Type (2019-2024) & ($ Millions)
Table 38. Europe Oncology Companion Diagnostic Market Size Market Share by Type (2019-2024)
Table 39. Europe Oncology Companion Diagnostic Market Size by Application (2019-2024) & ($ Millions)
Table 40. Europe Oncology Companion Diagnostic Market Size Market Share by Application (2019-2024)
Table 41. Middle East & Africa Oncology Companion Diagnostic Market Size by Region (2019-2024) & ($ Millions)
Table 42. Middle East & Africa Oncology Companion Diagnostic Market Size Market Share by Region (2019-2024)
Table 43. Middle East & Africa Oncology Companion Diagnostic Market Size by Type (2019-2024) & ($ Millions)
Table 44. Middle East & Africa Oncology Companion Diagnostic Market Size Market Share by Type (2019-2024)
Table 45. Middle East & Africa Oncology Companion Diagnostic Market Size by Application (2019-2024) & ($ Millions)
Table 46. Middle East & Africa Oncology Companion Diagnostic Market Size Market Share by Application (2019-2024)
Table 47. Key Market Drivers & Growth Opportunities of Oncology Companion Diagnostic
Table 48. Key Market Challenges & Risks of Oncology Companion Diagnostic
Table 49. Key Industry Trends of Oncology Companion Diagnostic
Table 50. Global Oncology Companion Diagnostic Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 51. Global Oncology Companion Diagnostic Market Size Market Share Forecast by Regions (2025-2030)
Table 52. Global Oncology Companion Diagnostic Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 53. Global Oncology Companion Diagnostic Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 54. Agilent Technologies, Inc. Details, Company Type, Oncology Companion Diagnostic Area Served and Its Competitors
Table 55. Agilent Technologies, Inc. Oncology Companion Diagnostic Product Offered
Table 56. Agilent Technologies, Inc. Oncology Companion Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 57. Agilent Technologies, Inc. Main Business
Table 58. Agilent Technologies, Inc. Latest Developments
Table 59. Illumina, Inc. Details, Company Type, Oncology Companion Diagnostic Area Served and Its Competitors
Table 60. Illumina, Inc. Oncology Companion Diagnostic Product Offered
Table 61. Illumina, Inc. Main Business
Table 62. Illumina, Inc. Oncology Companion Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 63. Illumina, Inc. Latest Developments
Table 64. Qiagen N.V. Details, Company Type, Oncology Companion Diagnostic Area Served and Its Competitors
Table 65. Qiagen N.V. Oncology Companion Diagnostic Product Offered
Table 66. Qiagen N.V. Main Business
Table 67. Qiagen N.V. Oncology Companion Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 68. Qiagen N.V. Latest Developments
Table 69. Thermo Fisher Scientific Inc. Details, Company Type, Oncology Companion Diagnostic Area Served and Its Competitors
Table 70. Thermo Fisher Scientific Inc. Oncology Companion Diagnostic Product Offered
Table 71. Thermo Fisher Scientific Inc. Main Business
Table 72. Thermo Fisher Scientific Inc. Oncology Companion Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 73. Thermo Fisher Scientific Inc. Latest Developments
Table 74. F. Hoffmann-La Roche Ltd. Details, Company Type, Oncology Companion Diagnostic Area Served and Its Competitors
Table 75. F. Hoffmann-La Roche Ltd. Oncology Companion Diagnostic Product Offered
Table 76. F. Hoffmann-La Roche Ltd. Main Business
Table 77. F. Hoffmann-La Roche Ltd. Oncology Companion Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 78. F. Hoffmann-La Roche Ltd. Latest Developments
Table 79. ARUP Laboratories Details, Company Type, Oncology Companion Diagnostic Area Served and Its Competitors
Table 80. ARUP Laboratories Oncology Companion Diagnostic Product Offered
Table 81. ARUP Laboratories Main Business
Table 82. ARUP Laboratories Oncology Companion Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 83. ARUP Laboratories Latest Developments
Table 84. Abbott Details, Company Type, Oncology Companion Diagnostic Area Served and Its Competitors
Table 85. Abbott Oncology Companion Diagnostic Product Offered
Table 86. Abbott Main Business
Table 87. Abbott Oncology Companion Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 88. Abbott Latest Developments
Table 89. Myriad Genetics, Inc. Details, Company Type, Oncology Companion Diagnostic Area Served and Its Competitors
Table 90. Myriad Genetics, Inc. Oncology Companion Diagnostic Product Offered
Table 91. Myriad Genetics, Inc. Main Business
Table 92. Myriad Genetics, Inc. Oncology Companion Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 93. Myriad Genetics, Inc. Latest Developments
Table 94. bioMйrieux SA Details, Company Type, Oncology Companion Diagnostic Area Served and Its Competitors
Table 95. bioMйrieux SA Oncology Companion Diagnostic Product Offered
Table 96. bioMйrieux SA Main Business
Table 97. bioMйrieux SA Oncology Companion Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 98. bioMйrieux SA Latest Developments
Table 99. Invivoscribe, Inc. Details, Company Type, Oncology Companion Diagnostic Area Served and Its Competitors
Table 100. Invivoscribe, Inc. Oncology Companion Diagnostic Product Offered
Table 101. Invivoscribe, Inc. Main Business
Table 102. Invivoscribe, Inc. Oncology Companion Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 103. Invivoscribe, Inc. Latest Developments
Table 1. Oncology Companion Diagnostic Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Polymerase Chain Reaction (PCR)
Table 3. Major Players of Next-Generation Sequencing (NGS)
Table 4. Major Players of Immunohistochemistry (IHC)
Table 5. Major Players of In situ hybridization (ISH)/Fluorescence in situ hybridization (FISH)
Table 6. Major Players of Others
Table 7. Oncology Companion Diagnostic Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 8. Global Oncology Companion Diagnostic Market Size by Type (2019-2024) & ($ Millions)
Table 9. Global Oncology Companion Diagnostic Market Size Market Share by Type (2019-2024)
Table 10. Oncology Companion Diagnostic Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 11. Global Oncology Companion Diagnostic Market Size by Application (2019-2024) & ($ Millions)
Table 12. Global Oncology Companion Diagnostic Market Size Market Share by Application (2019-2024)
Table 13. Global Oncology Companion Diagnostic Revenue by Players (2019-2024) & ($ Millions)
Table 14. Global Oncology Companion Diagnostic Revenue Market Share by Player (2019-2024)
Table 15. Oncology Companion Diagnostic Key Players Head office and Products Offered
Table 16. Oncology Companion Diagnostic Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Oncology Companion Diagnostic Market Size by Regions 2019-2024 & ($ Millions)
Table 20. Global Oncology Companion Diagnostic Market Size Market Share by Regions (2019-2024)
Table 21. Global Oncology Companion Diagnostic Revenue by Country/Region (2019-2024) & ($ millions)
Table 22. Global Oncology Companion Diagnostic Revenue Market Share by Country/Region (2019-2024)
Table 23. Americas Oncology Companion Diagnostic Market Size by Country (2019-2024) & ($ Millions)
Table 24. Americas Oncology Companion Diagnostic Market Size Market Share by Country (2019-2024)
Table 25. Americas Oncology Companion Diagnostic Market Size by Type (2019-2024) & ($ Millions)
Table 26. Americas Oncology Companion Diagnostic Market Size Market Share by Type (2019-2024)
Table 27. Americas Oncology Companion Diagnostic Market Size by Application (2019-2024) & ($ Millions)
Table 28. Americas Oncology Companion Diagnostic Market Size Market Share by Application (2019-2024)
Table 29. APAC Oncology Companion Diagnostic Market Size by Region (2019-2024) & ($ Millions)
Table 30. APAC Oncology Companion Diagnostic Market Size Market Share by Region (2019-2024)
Table 31. APAC Oncology Companion Diagnostic Market Size by Type (2019-2024) & ($ Millions)
Table 32. APAC Oncology Companion Diagnostic Market Size Market Share by Type (2019-2024)
Table 33. APAC Oncology Companion Diagnostic Market Size by Application (2019-2024) & ($ Millions)
Table 34. APAC Oncology Companion Diagnostic Market Size Market Share by Application (2019-2024)
Table 35. Europe Oncology Companion Diagnostic Market Size by Country (2019-2024) & ($ Millions)
Table 36. Europe Oncology Companion Diagnostic Market Size Market Share by Country (2019-2024)
Table 37. Europe Oncology Companion Diagnostic Market Size by Type (2019-2024) & ($ Millions)
Table 38. Europe Oncology Companion Diagnostic Market Size Market Share by Type (2019-2024)
Table 39. Europe Oncology Companion Diagnostic Market Size by Application (2019-2024) & ($ Millions)
Table 40. Europe Oncology Companion Diagnostic Market Size Market Share by Application (2019-2024)
Table 41. Middle East & Africa Oncology Companion Diagnostic Market Size by Region (2019-2024) & ($ Millions)
Table 42. Middle East & Africa Oncology Companion Diagnostic Market Size Market Share by Region (2019-2024)
Table 43. Middle East & Africa Oncology Companion Diagnostic Market Size by Type (2019-2024) & ($ Millions)
Table 44. Middle East & Africa Oncology Companion Diagnostic Market Size Market Share by Type (2019-2024)
Table 45. Middle East & Africa Oncology Companion Diagnostic Market Size by Application (2019-2024) & ($ Millions)
Table 46. Middle East & Africa Oncology Companion Diagnostic Market Size Market Share by Application (2019-2024)
Table 47. Key Market Drivers & Growth Opportunities of Oncology Companion Diagnostic
Table 48. Key Market Challenges & Risks of Oncology Companion Diagnostic
Table 49. Key Industry Trends of Oncology Companion Diagnostic
Table 50. Global Oncology Companion Diagnostic Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 51. Global Oncology Companion Diagnostic Market Size Market Share Forecast by Regions (2025-2030)
Table 52. Global Oncology Companion Diagnostic Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 53. Global Oncology Companion Diagnostic Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 54. Agilent Technologies, Inc. Details, Company Type, Oncology Companion Diagnostic Area Served and Its Competitors
Table 55. Agilent Technologies, Inc. Oncology Companion Diagnostic Product Offered
Table 56. Agilent Technologies, Inc. Oncology Companion Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 57. Agilent Technologies, Inc. Main Business
Table 58. Agilent Technologies, Inc. Latest Developments
Table 59. Illumina, Inc. Details, Company Type, Oncology Companion Diagnostic Area Served and Its Competitors
Table 60. Illumina, Inc. Oncology Companion Diagnostic Product Offered
Table 61. Illumina, Inc. Main Business
Table 62. Illumina, Inc. Oncology Companion Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 63. Illumina, Inc. Latest Developments
Table 64. Qiagen N.V. Details, Company Type, Oncology Companion Diagnostic Area Served and Its Competitors
Table 65. Qiagen N.V. Oncology Companion Diagnostic Product Offered
Table 66. Qiagen N.V. Main Business
Table 67. Qiagen N.V. Oncology Companion Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 68. Qiagen N.V. Latest Developments
Table 69. Thermo Fisher Scientific Inc. Details, Company Type, Oncology Companion Diagnostic Area Served and Its Competitors
Table 70. Thermo Fisher Scientific Inc. Oncology Companion Diagnostic Product Offered
Table 71. Thermo Fisher Scientific Inc. Main Business
Table 72. Thermo Fisher Scientific Inc. Oncology Companion Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 73. Thermo Fisher Scientific Inc. Latest Developments
Table 74. F. Hoffmann-La Roche Ltd. Details, Company Type, Oncology Companion Diagnostic Area Served and Its Competitors
Table 75. F. Hoffmann-La Roche Ltd. Oncology Companion Diagnostic Product Offered
Table 76. F. Hoffmann-La Roche Ltd. Main Business
Table 77. F. Hoffmann-La Roche Ltd. Oncology Companion Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 78. F. Hoffmann-La Roche Ltd. Latest Developments
Table 79. ARUP Laboratories Details, Company Type, Oncology Companion Diagnostic Area Served and Its Competitors
Table 80. ARUP Laboratories Oncology Companion Diagnostic Product Offered
Table 81. ARUP Laboratories Main Business
Table 82. ARUP Laboratories Oncology Companion Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 83. ARUP Laboratories Latest Developments
Table 84. Abbott Details, Company Type, Oncology Companion Diagnostic Area Served and Its Competitors
Table 85. Abbott Oncology Companion Diagnostic Product Offered
Table 86. Abbott Main Business
Table 87. Abbott Oncology Companion Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 88. Abbott Latest Developments
Table 89. Myriad Genetics, Inc. Details, Company Type, Oncology Companion Diagnostic Area Served and Its Competitors
Table 90. Myriad Genetics, Inc. Oncology Companion Diagnostic Product Offered
Table 91. Myriad Genetics, Inc. Main Business
Table 92. Myriad Genetics, Inc. Oncology Companion Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 93. Myriad Genetics, Inc. Latest Developments
Table 94. bioMйrieux SA Details, Company Type, Oncology Companion Diagnostic Area Served and Its Competitors
Table 95. bioMйrieux SA Oncology Companion Diagnostic Product Offered
Table 96. bioMйrieux SA Main Business
Table 97. bioMйrieux SA Oncology Companion Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 98. bioMйrieux SA Latest Developments
Table 99. Invivoscribe, Inc. Details, Company Type, Oncology Companion Diagnostic Area Served and Its Competitors
Table 100. Invivoscribe, Inc. Oncology Companion Diagnostic Product Offered
Table 101. Invivoscribe, Inc. Main Business
Table 102. Invivoscribe, Inc. Oncology Companion Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 103. Invivoscribe, Inc. Latest Developments
LIST OF FIGURES
Figure 1. Oncology Companion Diagnostic Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Oncology Companion Diagnostic Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Oncology Companion Diagnostic Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Oncology Companion Diagnostic Sales Market Share by Country/Region (2023)
Figure 8. Oncology Companion Diagnostic Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Oncology Companion Diagnostic Market Size Market Share by Type in 2023
Figure 10. Oncology Companion Diagnostic in Hospital
Figure 11. Global Oncology Companion Diagnostic Market: Hospital (2019-2024) & ($ Millions)
Figure 12. Oncology Companion Diagnostic in Pathology/Diagnostic Laboratory
Figure 13. Global Oncology Companion Diagnostic Market: Pathology/Diagnostic Laboratory (2019-2024) & ($ Millions)
Figure 14. Oncology Companion Diagnostic in Academic Medical Center
Figure 15. Global Oncology Companion Diagnostic Market: Academic Medical Center (2019-2024) & ($ Millions)
Figure 16. Global Oncology Companion Diagnostic Market Size Market Share by Application in 2023
Figure 17. Global Oncology Companion Diagnostic Revenue Market Share by Player in 2023
Figure 18. Global Oncology Companion Diagnostic Market Size Market Share by Regions (2019-2024)
Figure 19. Americas Oncology Companion Diagnostic Market Size 2019-2024 ($ Millions)
Figure 20. APAC Oncology Companion Diagnostic Market Size 2019-2024 ($ Millions)
Figure 21. Europe Oncology Companion Diagnostic Market Size 2019-2024 ($ Millions)
Figure 22. Middle East & Africa Oncology Companion Diagnostic Market Size 2019-2024 ($ Millions)
Figure 23. Americas Oncology Companion Diagnostic Value Market Share by Country in 2023
Figure 24. United States Oncology Companion Diagnostic Market Size Growth 2019-2024 ($ Millions)
Figure 25. Canada Oncology Companion Diagnostic Market Size Growth 2019-2024 ($ Millions)
Figure 26. Mexico Oncology Companion Diagnostic Market Size Growth 2019-2024 ($ Millions)
Figure 27. Brazil Oncology Companion Diagnostic Market Size Growth 2019-2024 ($ Millions)
Figure 28. APAC Oncology Companion Diagnostic Market Size Market Share by Region in 2023
Figure 29. APAC Oncology Companion Diagnostic Market Size Market Share by Type in 2023
Figure 30. APAC Oncology Companion Diagnostic Market Size Market Share by Application in 2023
Figure 31. China Oncology Companion Diagnostic Market Size Growth 2019-2024 ($ Millions)
Figure 32. Japan Oncology Companion Diagnostic Market Size Growth 2019-2024 ($ Millions)
Figure 33. Korea Oncology Companion Diagnostic Market Size Growth 2019-2024 ($ Millions)
Figure 34. Southeast Asia Oncology Companion Diagnostic Market Size Growth 2019-2024 ($ Millions)
Figure 35. India Oncology Companion Diagnostic Market Size Growth 2019-2024 ($ Millions)
Figure 36. Australia Oncology Companion Diagnostic Market Size Growth 2019-2024 ($ Millions)
Figure 37. Europe Oncology Companion Diagnostic Market Size Market Share by Country in 2023
Figure 38. Europe Oncology Companion Diagnostic Market Size Market Share by Type (2019-2024)
Figure 39. Europe Oncology Companion Diagnostic Market Size Market Share by Application (2019-2024)
Figure 40. Germany Oncology Companion Diagnostic Market Size Growth 2019-2024 ($ Millions)
Figure 41. France Oncology Companion Diagnostic Market Size Growth 2019-2024 ($ Millions)
Figure 42. UK Oncology Companion Diagnostic Market Size Growth 2019-2024 ($ Millions)
Figure 43. Italy Oncology Companion Diagnostic Market Size Growth 2019-2024 ($ Millions)
Figure 44. Russia Oncology Companion Diagnostic Market Size Growth 2019-2024 ($ Millions)
Figure 45. Middle East & Africa Oncology Companion Diagnostic Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Oncology Companion Diagnostic Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa Oncology Companion Diagnostic Market Size Market Share by Application (2019-2024)
Figure 48. Egypt Oncology Companion Diagnostic Market Size Growth 2019-2024 ($ Millions)
Figure 49. South Africa Oncology Companion Diagnostic Market Size Growth 2019-2024 ($ Millions)
Figure 50. Israel Oncology Companion Diagnostic Market Size Growth 2019-2024 ($ Millions)
Figure 51. Turkey Oncology Companion Diagnostic Market Size Growth 2019-2024 ($ Millions)
Figure 52. GCC Country Oncology Companion Diagnostic Market Size Growth 2019-2024 ($ Millions)
Figure 53. Americas Oncology Companion Diagnostic Market Size 2025-2030 ($ Millions)
Figure 54. APAC Oncology Companion Diagnostic Market Size 2025-2030 ($ Millions)
Figure 55. Europe Oncology Companion Diagnostic Market Size 2025-2030 ($ Millions)
Figure 56. Middle East & Africa Oncology Companion Diagnostic Market Size 2025-2030 ($ Millions)
Figure 57. United States Oncology Companion Diagnostic Market Size 2025-2030 ($ Millions)
Figure 58. Canada Oncology Companion Diagnostic Market Size 2025-2030 ($ Millions)
Figure 59. Mexico Oncology Companion Diagnostic Market Size 2025-2030 ($ Millions)
Figure 60. Brazil Oncology Companion Diagnostic Market Size 2025-2030 ($ Millions)
Figure 61. China Oncology Companion Diagnostic Market Size 2025-2030 ($ Millions)
Figure 62. Japan Oncology Companion Diagnostic Market Size 2025-2030 ($ Millions)
Figure 63. Korea Oncology Companion Diagnostic Market Size 2025-2030 ($ Millions)
Figure 64. Southeast Asia Oncology Companion Diagnostic Market Size 2025-2030 ($ Millions)
Figure 65. India Oncology Companion Diagnostic Market Size 2025-2030 ($ Millions)
Figure 66. Australia Oncology Companion Diagnostic Market Size 2025-2030 ($ Millions)
Figure 67. Germany Oncology Companion Diagnostic Market Size 2025-2030 ($ Millions)
Figure 68. France Oncology Companion Diagnostic Market Size 2025-2030 ($ Millions)
Figure 69. UK Oncology Companion Diagnostic Market Size 2025-2030 ($ Millions)
Figure 70. Italy Oncology Companion Diagnostic Market Size 2025-2030 ($ Millions)
Figure 71. Russia Oncology Companion Diagnostic Market Size 2025-2030 ($ Millions)
Figure 72. Spain Oncology Companion Diagnostic Market Size 2025-2030 ($ Millions)
Figure 73. Egypt Oncology Companion Diagnostic Market Size 2025-2030 ($ Millions)
Figure 74. South Africa Oncology Companion Diagnostic Market Size 2025-2030 ($ Millions)
Figure 75. Israel Oncology Companion Diagnostic Market Size 2025-2030 ($ Millions)
Figure 76. Turkey Oncology Companion Diagnostic Market Size 2025-2030 ($ Millions)
Figure 77. GCC Countries Oncology Companion Diagnostic Market Size 2025-2030 ($ Millions)
Figure 78. Global Oncology Companion Diagnostic Market Size Market Share Forecast by Type (2025-2030)
Figure 79. Global Oncology Companion Diagnostic Market Size Market Share Forecast by Application (2025-2030)
Figure 1. Oncology Companion Diagnostic Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Oncology Companion Diagnostic Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Oncology Companion Diagnostic Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Oncology Companion Diagnostic Sales Market Share by Country/Region (2023)
Figure 8. Oncology Companion Diagnostic Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Oncology Companion Diagnostic Market Size Market Share by Type in 2023
Figure 10. Oncology Companion Diagnostic in Hospital
Figure 11. Global Oncology Companion Diagnostic Market: Hospital (2019-2024) & ($ Millions)
Figure 12. Oncology Companion Diagnostic in Pathology/Diagnostic Laboratory
Figure 13. Global Oncology Companion Diagnostic Market: Pathology/Diagnostic Laboratory (2019-2024) & ($ Millions)
Figure 14. Oncology Companion Diagnostic in Academic Medical Center
Figure 15. Global Oncology Companion Diagnostic Market: Academic Medical Center (2019-2024) & ($ Millions)
Figure 16. Global Oncology Companion Diagnostic Market Size Market Share by Application in 2023
Figure 17. Global Oncology Companion Diagnostic Revenue Market Share by Player in 2023
Figure 18. Global Oncology Companion Diagnostic Market Size Market Share by Regions (2019-2024)
Figure 19. Americas Oncology Companion Diagnostic Market Size 2019-2024 ($ Millions)
Figure 20. APAC Oncology Companion Diagnostic Market Size 2019-2024 ($ Millions)
Figure 21. Europe Oncology Companion Diagnostic Market Size 2019-2024 ($ Millions)
Figure 22. Middle East & Africa Oncology Companion Diagnostic Market Size 2019-2024 ($ Millions)
Figure 23. Americas Oncology Companion Diagnostic Value Market Share by Country in 2023
Figure 24. United States Oncology Companion Diagnostic Market Size Growth 2019-2024 ($ Millions)
Figure 25. Canada Oncology Companion Diagnostic Market Size Growth 2019-2024 ($ Millions)
Figure 26. Mexico Oncology Companion Diagnostic Market Size Growth 2019-2024 ($ Millions)
Figure 27. Brazil Oncology Companion Diagnostic Market Size Growth 2019-2024 ($ Millions)
Figure 28. APAC Oncology Companion Diagnostic Market Size Market Share by Region in 2023
Figure 29. APAC Oncology Companion Diagnostic Market Size Market Share by Type in 2023
Figure 30. APAC Oncology Companion Diagnostic Market Size Market Share by Application in 2023
Figure 31. China Oncology Companion Diagnostic Market Size Growth 2019-2024 ($ Millions)
Figure 32. Japan Oncology Companion Diagnostic Market Size Growth 2019-2024 ($ Millions)
Figure 33. Korea Oncology Companion Diagnostic Market Size Growth 2019-2024 ($ Millions)
Figure 34. Southeast Asia Oncology Companion Diagnostic Market Size Growth 2019-2024 ($ Millions)
Figure 35. India Oncology Companion Diagnostic Market Size Growth 2019-2024 ($ Millions)
Figure 36. Australia Oncology Companion Diagnostic Market Size Growth 2019-2024 ($ Millions)
Figure 37. Europe Oncology Companion Diagnostic Market Size Market Share by Country in 2023
Figure 38. Europe Oncology Companion Diagnostic Market Size Market Share by Type (2019-2024)
Figure 39. Europe Oncology Companion Diagnostic Market Size Market Share by Application (2019-2024)
Figure 40. Germany Oncology Companion Diagnostic Market Size Growth 2019-2024 ($ Millions)
Figure 41. France Oncology Companion Diagnostic Market Size Growth 2019-2024 ($ Millions)
Figure 42. UK Oncology Companion Diagnostic Market Size Growth 2019-2024 ($ Millions)
Figure 43. Italy Oncology Companion Diagnostic Market Size Growth 2019-2024 ($ Millions)
Figure 44. Russia Oncology Companion Diagnostic Market Size Growth 2019-2024 ($ Millions)
Figure 45. Middle East & Africa Oncology Companion Diagnostic Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Oncology Companion Diagnostic Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa Oncology Companion Diagnostic Market Size Market Share by Application (2019-2024)
Figure 48. Egypt Oncology Companion Diagnostic Market Size Growth 2019-2024 ($ Millions)
Figure 49. South Africa Oncology Companion Diagnostic Market Size Growth 2019-2024 ($ Millions)
Figure 50. Israel Oncology Companion Diagnostic Market Size Growth 2019-2024 ($ Millions)
Figure 51. Turkey Oncology Companion Diagnostic Market Size Growth 2019-2024 ($ Millions)
Figure 52. GCC Country Oncology Companion Diagnostic Market Size Growth 2019-2024 ($ Millions)
Figure 53. Americas Oncology Companion Diagnostic Market Size 2025-2030 ($ Millions)
Figure 54. APAC Oncology Companion Diagnostic Market Size 2025-2030 ($ Millions)
Figure 55. Europe Oncology Companion Diagnostic Market Size 2025-2030 ($ Millions)
Figure 56. Middle East & Africa Oncology Companion Diagnostic Market Size 2025-2030 ($ Millions)
Figure 57. United States Oncology Companion Diagnostic Market Size 2025-2030 ($ Millions)
Figure 58. Canada Oncology Companion Diagnostic Market Size 2025-2030 ($ Millions)
Figure 59. Mexico Oncology Companion Diagnostic Market Size 2025-2030 ($ Millions)
Figure 60. Brazil Oncology Companion Diagnostic Market Size 2025-2030 ($ Millions)
Figure 61. China Oncology Companion Diagnostic Market Size 2025-2030 ($ Millions)
Figure 62. Japan Oncology Companion Diagnostic Market Size 2025-2030 ($ Millions)
Figure 63. Korea Oncology Companion Diagnostic Market Size 2025-2030 ($ Millions)
Figure 64. Southeast Asia Oncology Companion Diagnostic Market Size 2025-2030 ($ Millions)
Figure 65. India Oncology Companion Diagnostic Market Size 2025-2030 ($ Millions)
Figure 66. Australia Oncology Companion Diagnostic Market Size 2025-2030 ($ Millions)
Figure 67. Germany Oncology Companion Diagnostic Market Size 2025-2030 ($ Millions)
Figure 68. France Oncology Companion Diagnostic Market Size 2025-2030 ($ Millions)
Figure 69. UK Oncology Companion Diagnostic Market Size 2025-2030 ($ Millions)
Figure 70. Italy Oncology Companion Diagnostic Market Size 2025-2030 ($ Millions)
Figure 71. Russia Oncology Companion Diagnostic Market Size 2025-2030 ($ Millions)
Figure 72. Spain Oncology Companion Diagnostic Market Size 2025-2030 ($ Millions)
Figure 73. Egypt Oncology Companion Diagnostic Market Size 2025-2030 ($ Millions)
Figure 74. South Africa Oncology Companion Diagnostic Market Size 2025-2030 ($ Millions)
Figure 75. Israel Oncology Companion Diagnostic Market Size 2025-2030 ($ Millions)
Figure 76. Turkey Oncology Companion Diagnostic Market Size 2025-2030 ($ Millions)
Figure 77. GCC Countries Oncology Companion Diagnostic Market Size 2025-2030 ($ Millions)
Figure 78. Global Oncology Companion Diagnostic Market Size Market Share Forecast by Type (2025-2030)
Figure 79. Global Oncology Companion Diagnostic Market Size Market Share Forecast by Application (2025-2030)
